How Do We Build Better Medicines Without Relying on Animal Testing? with Dr. Yassen Abbas from CN Bio

In this episode of Pulse, Aldo sits down with Dr. Yassen Abbas, Biology Group Leader at CN Bio, to explore how organ-on-a-chip technology is transforming the future of biotechnology, drug discovery, and personalised medicine.They discuss how these sophisticated human tissue models are helping researchers predict drug safety and effectiveness more accurately than traditional laboratory methods, why AI is becoming an essential partner in pharmaceutical research, and how advances in synthetic biology and genomics are bringing us closer to truly personalised healthcare.From the changing regulatory landscape to the promise of multi-organ systems, rare disease research, and the convergence of engineering, biology, and artificial intelligence, this is a conversation about the technologies that could redefine how new medicines are developed.Sincerely hope you will enjoy this conversation with Dr. Yassen Abbas.You can find out more about CN Bio here: https://cn-bio.com/Watch this episode on YouTube: https://www.youtube.com/@AlphaWireHQThis episode was brought together by AlphaWire: https://alphawire.xyz/